AR and breast cancer: PD-1 binding to PD-L1 specifically inhibits T-cell activation and represents one mechanism of immune tumour escape.6 TNBCs are thought to be more immunogenic than other BC and AR + TNBC show a higher frequency of PD-L1 expression.7